gadolinium dtpa has been researched along with melphalan in 2 studies
| Studies (gadolinium dtpa) | Trials (gadolinium dtpa) | Recent Studies (post-2010) (gadolinium dtpa) | Studies (melphalan) | Trials (melphalan) | Recent Studies (post-2010) (melphalan) |
|---|---|---|---|---|---|
| 12,654 | 664 | 4,051 | 8,134 | 1,351 | 1,972 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bloem, JL; Geirnaerdt, MJ; Hogendoorn, PC; Kroon, BB; Peterse, JL; Taminiau, AH; Tollenaar, RA; van Coevorden, F; van Rijswijk, CS | 1 |
| Ambagtsheer, G; Eggermont, AM; Krestin, GP; Preda, A; Ten Hagen, TL; van Dijke, CF; van Tiel, ST; van Vliet, M; Veenland, JF; Vogel, MW; Wielopolski, PA | 1 |
2 other study(ies) available for gadolinium dtpa and melphalan
| Article | Year |
|---|---|
Dynamic contrast-enhanced MR imaging in monitoring response to isolated limb perfusion in high-grade soft tissue sarcoma: initial results.
Topics: Antineoplastic Agents; Chemotherapy, Cancer, Regional Perfusion; Contrast Media; Extremities; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Melphalan; Middle Aged; Sarcoma; Tumor Necrosis Factor-alpha | 2003 |
Dynamic contrast-enhanced MRI using macromolecular contrast media for monitoring the response to isolated limb perfusion in experimental soft-tissue sarcomas.
Topics: Albumins; Animals; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Contrast Media; Extremities; Gadolinium DTPA; Image Enhancement; Macromolecular Substances; Magnetic Resonance Imaging; Male; Melphalan; Prognosis; Rats; Rats, Inbred BN; Sarcoma, Experimental; Treatment Outcome; Tumor Necrosis Factor-alpha | 2004 |